Endobronchial argon plasma coagulation for treatment of dieulafoy disease

23Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Dieulafoy disease of the bronchus is a rare condition. A 28-y-old male patient with recurrent exacerbations of hemoptysis (producing up to 300 mL) over the previous 4 y was admitted to our hospital following an acute episode. A 3-mm sessile lesion covered with somewhat ulcerated smooth mucosa was detected at the distal end of the left main bronchus, at the entrance to the upper lobe bronchus. Bleeding was controlled by argon plasma coagulation, and total coagulation of the lesion was also therapeutic. The patient has been followed for 2 y with no further bleeding. In the very few reported cases of Dieulafoy disease, surgical resection and selective embolization were the treatments used. Endobronchial treatment has not been described before as a therapeutic approach. We emphasize that argon plasma coagulation can be a treatment option in such cases.

Cite

CITATION STYLE

APA

Dalar, L., Sökücü, S. N., ÖZdemir, C., Büyükkale, S., & Altın, S. (2015). Endobronchial argon plasma coagulation for treatment of dieulafoy disease. Respiratory Care, 60(1), e11–e13. https://doi.org/10.4187/respcare.03307

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free